The effect of supplementing Lactococcus lactis (L. lactis) that was engineered to express epidermal growth factor (EGF-LL) to early-weaned pigs fed diets with typical levels of blood plasma (5%) or diets without blood plasma [blood plasma was substituted with soybean (Glycine max) meal and fi sh meal, based on amino acid supply] was examined. A total of 108 weaned piglets (19-26 d of age; mean initial BW 6.58 kg; 9 pigs per pen) were fed ad libitum according to a 2-phase feeding program without growth promoters. Three pens were assigned to each of 4 treatments: i) blood plasma-containing diet with blank bacterial growth medium (BP-Con), ii) blood plasma-containing diet with fermented EGF-LL (BP-EGF), iii) blood plasma-free diet with blank bacterial growth medium (BPF-Con), and iv) blood plasma-free diet with fermented EGF-LL (BPF-EGF). The amount of epidermal growth factor (EGF) was determined in the fermentation product and pigs were allotted 60 μg EGF/kg BW/d for 3 wk postweaning. There were no differences in overall growth performance between BPCon and BP-EGF pigs and no differences in overall growth performance between LoCon and BPF-EGF pigs. Pigs fed BPF-EGF showed increased daily BW gain (410 vs. 260 g/d; P < 0.01) and gain:feed (0.67 vs. 0.58; P < 0.05) compared to BPF-Con pigs in wk 3 postweaning; this was comparable to values for the BPCon group (400 g/d and 0.64). These results indicate that supplementation with EGF-LL can be effective in enhancing the performance of early-weaned piglets fed a low complexity diet and reduces the need for feeding high-quality animal proteins and antibiotics.
INTRODUCTION
Early weaning of pigs can lead to postweaning diarrhea, reduced feed intake, reduced nutrient digestion and absorption, and a lag in growth performance (Gu et al., 2002) . One strategy to improve feed intake and gut health after weaning is the addition of animal proteins (AP), such as blood plasma, to the feed, which are generally more digestible than plant proteins and can provide functional proteins that stimulate gut health and development. However, AP are generally more expensive and contribute to food safety concerns (Sapkota et al., 2007) . Spray-dried porcine blood plasma contains immunoglobulins and growth factors, including epidermal growth factor (EGF) that may add to their benefi cial effects (van Dijk, 2001 ), which stimulate cell proliferation and differentiation.
Lactococcus lactis is a food grade, gram-positive lactic acid bacteria that is metabolically active throughout the intestinal tract (Drouault et al., 1999) . We previously generated porcine EGF-secreting recombinant L. lactis (EGF-LL) and showed its ability to enhance body weight gain of early-weaned mice (Mus musculus) (Cheung et al., 2009 ) and increased villus height as well as intestine cell proliferation in earlyweaned pigs (Kang et al., 2010) . The objective of the current investigation was to study if supplementing a blood plasma-free diet with EGF-secreting L. lactiscan improve early weaned piglet intestine development and performance compared to a nonsupplemented diet containing blood plasma.
MATERIALS AND METHODS
The EGF-LL was generated as previously described (Cheung et al., 2009 ) and fermented in M17 broth (Oxoid, Basingstoke, United Kingdom) with 1% glucose and 1 μg/mL erythromycin (M17GE broth). Elevenhour fermentations were performed in a Beauty-CN fermentor under the following conditions: 3.2L M17GE broth, 32ºC, 40 revolutions/min agitation, pH 6.25, and 20 g/L glucose.
Pigs (Landrace × Yorkshire), weaned at 19-26 d of age, were randomly assigned to 1 of the following treatments: i) blood plasma-containing diet with M17GE broth (BP-Con), ii) blood plasma-containing diet with fermented EGF-LL (BP-EGF), iii) blood plasma-free diet with M17GE broth (BPF-Con), or (iv) blood plasmafree diet with fermented EGF-LL (BPF-EGF). Pigs were divided into 12 pens of 9 pigs per pen and 3 pens per treatment. Each pen had an average initial BW between 6.5 and 6.6 kg with 4 male and 5 female pigs. Diets were based on corn (Zea mays) and soybean meal and contained similar nutrient levels and no antibiotics but differed in their AP contents. Blood plasma-containing diets included 1% fi shmeal and 5% blood plasma; blood plasma-free diets included 4.9% fi shmeal and no blood plasma. Concentration of EGF in the fermentation product was 3 ng/μL. The BP-EGF and BPF-EGF pigs were given 80 μg/kg BW/d of EGF throughout the trial, but BP-Con and BPF-Con pigs were given matching volumes of M17GE broth. Broth or fermentation products were mixed with feed twice daily at 0730 and 1930 h for 21 d. Pigs had ad libitum access to water and feed; remaining feed was weighed back at 0700 each day. Body weights of individual pigs were recorded every 7 d.
Twenty-one days after weaning, ten 1-cm jejunal cross-sections were taken 1 m distal of the pylorus immediately following euthanasia from two pigs per pen. Tissue was frozen immediately in liquid N and then lyophilized. Lyophilized samples were homogenized in 50 mM D-mannitol, pH 7.4, and centrifuged. This supernatant was used for enzyme analysis. Sucrase levels were determined as previously described (Kelly et al., 1991) . Alkaline phosphatase levels were determined as previously described (Lackeyram et al., 2010) . Protein content was determined with a Bio-Rad protein assay kit (Bio-Rad) using bovine serum albumin as a standard. The data were analyzed by ANOVA using Prism version 5.0b analysis software (GraphPad Software, Inc., La Jolla, CA); Tukey's test for multiple comparisons was performed to determine statistical differences between groups. Treatment effects were considered signifi cant at P < 0.05 and a trend at 0.05 < P < 0.10.
RESULTS AND DISCUSSION
Although similar in nutrient content, pigs fed the blood plasma-containing diet had better growth performance compared to pigs fed the blood plasma-free diet ( Table 1) . As shown in Table 1 , while no differences in growth performance were observed between BPCon and BP-EGF (P > 0.10), BPF-EGF pigs showed increased daily BW gain (410 vs. 260 g/d; P < 0.01) and gain:feed (0.67 vs. 0.58; P < 0.05) compared to BPF-Con pigs during week 3 after weaning; this was comparable to the performance of the BP-Con group (400 g/d). The overall growth performance was similar for BPF-Con Means within a row without common superscripts differ (P < 0.05). 1 Dietary treatments were blood plasma-containing (BP) or blood plasma-free (BPF) diets with either M17 broth (Con) or fermentation product containing epidermal growth factor (EGF) secreting Lactococcus lactis. Mean of 3 pens per treatment with 9 pigs per pen. and BPF-EGF pigs (P < 0.10), possibly due to the lack of response to EGF-LL in wk 1. The fact that no differences were observed between BP-Con and BP-EGF may be due to the fact that blood plasma already contains EGF and other intestine growth stimulators, and therefore the piglets did not require supplemental EGF to improve performance.
Sucrase and alkaline phosphatase are responsible for the fi nal stages of macronutrient digestion, and thus their activity levels refl ect the maturation of intestine (Lackeyram et al., 2010) . Intestinal alkaline phosphatase is regarded as a key marker enzyme when considering changes in the primary digestive and absorptive functions of the small intestine (Lackeyram et al., 2010) . As shown in Figure 1 , while no difference was shown between the BP-EGF and BP-Con groups, alkaline phosphatase levels in the BPF-EGF group were higher than the BPF-Con group (P < 0.05). In addition there was a trend (P < 0.10) for both EGF groups to have higher levels of sucrase than their controls.
We have previously demonstrated that EGF-LL feeding to early-weaned pig increased proliferation of intestinal cells (Kang et al., 2010) . This, together with the current fi nding that the recombinant L. lactis enhanced intestinal maturation status, refl ected by the increased alkaline phosphatase activity, may be responsible for the increased gain:feed ratio and BW gain of earlyweaned pigs. Our fi ndings suggest that L. lactis may be an alternative means to deliver benefi cial factors to the intestine and replace in-feed blood plasma.
